selenocysteine has been researched along with Colonic Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badmaev, V; Ho, CT; Kuo, FL; Lai, CS; Pan, MH; Tsai, ML; Tung, YC | 1 |
Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
Cervinka, M; Hasková, P; Králová, V; Rudolf, E; Schröterová, L; Vorácová, A | 1 |
Bhattacharya, A; Hoffman, RM; Rajput, A; Rustum, YM; San Martin, ID; Seshadri, M; Turowski, SG | 1 |
Cao, S; Durrani, FA; Rustum, YM | 1 |
5 other study(ies) available for selenocysteine and Colonic Neoplasms
Article | Year |
---|---|
Se-Methyl-L-selenocysteine Induces Apoptosis via Endoplasmic Reticulum Stress and the Death Receptor Pathway in Human Colon Adenocarcinoma COLO 205 Cells.
Topics: Adenocarcinoma; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Colonic Neoplasms; Endoplasmic Reticulum Stress; Humans; Poly(ADP-ribose) Polymerases; Selenocysteine; Transcription Factor CHOP | 2015 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |
Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cysteine; Cytotoxins; Humans; Methionine; Organoselenium Compounds; Selenocysteine; Sodium Selenite; Toxicity Tests | 2009 |
Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Cysteine; Diagnostic Imaging; Female; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microvessels; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Selenocysteine; Xenograft Model Antitumor Assays | 2011 |
Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; Colonic Neoplasms; Cysteine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Irinotecan; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organoselenium Compounds; Radiation-Sensitizing Agents; Selenium; Selenocysteine; Selenomethionine; Time Factors | 2004 |